MedTrace Logo

Early Screening for Gestational Diabetes Mellitus

NCT01026675 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1442

Last updated 2018-05-03

No results posted yet for this study

Summary

The working hypothesis of this proposal is that screening for gestational diabetes mellitus as early as the 1st trimester is efficient for detecting the forthcoming presence or absence of gestational diabetes mellitus. The investigators long-term goal is the prevention of gestational diabetes mellitus onset i.e. the prevention of progression to gestational diabetes mellitus, in order to enable delivery of appropriate counselling, diagnostics and treatment for pregnant women, as well as to improve pregnancy outcomes. Therefore, robust 1st trimester screening criteria is needed.

The overall objective of this proposal is to determine an accurate and valid 1st trimester 1h post 50g oral glucose challenge test plasma glucose cut-off value that is predictive of gestational diabetes mellitus onset.

Conditions

  • Gestational Diabetes Mellitus

Interventions

PROCEDURE

50 g oral glucose challenge test - 75 g oral glucose tolerance test

50 g oral glucose challenge test at 6-13 weeks of gestation and 75 g oral glucose tolerance test at 24-28 weeks of gestation.

Sponsors & Collaborators

  • Canadian Diabetes Association

    collaborator OTHER

  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Jean-Luc Ardilouze, MD, PhD · Université de Sherbrooke

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2012-12-31
Completion
2013-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01026675 on ClinicalTrials.gov